Clinical evaluation of a new oral retinoid RO10 9359 in the treatment of Darier's disease.
D000328:Adult; D000368:Aged; D007644:Darier Disease / Q000188:drug therapy*; D004341:Drug Evaluation; D005050:Etretinate / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014212:Tretinoin / Q000031:analogs & derivatives*
D014212:Tretinoin; D005050:Etretinate